MVA newsletter no 02, February 2005

: MVA HIGHLIGHT: MVA and StepStone launch new job site
by Mia Riise Hansen, Web Editor & Project Manager, Medicon Valley Academy



This week, Medicon Valley Academy (MVA) in collaboration with StepStone in Sweden and Denmark, launches a Medicon Valley job site with available jobs within research, development, manufacturing and health care in the biotech, medtech and pharma sector in the Øresund region: www.mva.org/jobs

Here you can view the listings from all MVA member companies and organisations with job ads on StepStone's sites in Sweden and Denmark.

Via the MVA job site, StepStone also gives you the opportunity to participate in the hidden job market by registering your CV in their searchable database - completely free of charge. Recruiters use the database to locate candidates that best match their recruitment needs - sometimes before their vacancy is even advertised. And you are of course able to apply online using your CV for almost every job opportunity on the job site.

In addition, StepStone and MVA have worked out a very favourable one-off advertising package (to the value of DKK 16,490) which is free of charge for MVA members advertising on StepStone:

- One job ad on StepStone
- One banner ad on StepStone
- Free access to the StepStone CV database for one month

MVA members which are not advertising on StepStone will still have the opportunity to publish their job ads free of charge on the job site.

Good luck in finding your future employee or job!
Go to the job site


: NEWS INDEX

• Small Talk on Big Issues: Nanoscience & Nanotechnologies - risks and opportunities - 9 February 
• MVA Seminar: From pre-clinical projects to licensing - 14 February
• MVA journalist seminar: Nanotechnology - 23 February 
• Drug development network meeting: Industry-Academia partnerships - how can you get financing from the EU for your cooperation? - 2 March
• UK-Medicon Valley Drug Development Seminar and Partnering Event - 3 March
• MVA Annual Meeting 2005 - 30 March
• 6th Medicon Valley - Hepatocyte User Group Meeting - 6 April
• MVA Biostatistics Network Course: Clinical trial simulation in drug development - 18-20 April
• Symhogen (Denmark) named among Europe's top 100 private tech companies by Tornador Insider
• MIP Technologies (Sweden) and FeF Chemicals, a subsidiary of Novo Nordisk (Denmark), sign research and development agreement
• The Swedish Industrial Development Fund appoints new CEO 
• Vivolution (Denmark) has been awarded with the prestigious Product Innovation Award for their Vivostat System
• UK Global Partnership Programme
• EU award to team led by Lund University Hospital and Lund University
• The Swedish Research Council's Industry PhD Programme - deadline: 19 April
• Ultrazonix (Sweden) raises SEK 30 million in a new investment round

: MVA NEWS

Small Talk on Big Issues - Nanoscience & Nanotechnologies - risks and opportunities
9 February 2005 / Lund University / Sweden
The British Embassies in Sweden and Denmark in co-operation with the Biomedical Centre of Lund University, Medicon Valley Academy, Nordiska Forskningsnätet, Pronano AB and the association Vetenskap och Allmänhet invites you to a half-day discussion workshop, about risks and opportunities with Nanoscience and Nanotechnologies.
Read more here (in English) www.mva.org/composite-1327.htm

MVA Seminar: From pre-clinical projects to licensing
14 February 2005 / Ørestad / Copenhagen / Denmark
This seminar addresses questions arising during early clinical development from a clinical perspective and related business decisions. It will help you to avoid pitfalls and to reduce risk.
Read more here (in English) www.mva.org/composite-1365.htm

MVA journalist seminar: Nanotechnology
23 February 2005 / Ørestad / Copenhagen /Denmark
Medicon Valley Academy has initiated a series of journalist seminars focusing on groundbreaking research and development. Next seminar focuses on nanotechnology. Speakers are Thomas Bjørnholm, professor and head of Nano-Science Center, University of Copenhagen, and Martin Roland Jensen, Research Director, T-Cellic A/S.

Drug development network meeting: Industry-Academia partnerships - how can you get financing from the EU for your cooperation?
2 March 2005 / Ørestad / Copenhagen / Denmark
This MVA drug development meeting will focus on the Marie Curie European Framework Programme, and specifically on the Industry-Academia Partnerships, a type of project explicitly designed to facilitate long-term co-operations between companies and academic research groups. Speaker is Ulla Mortensen from SIK, the Swedish Institute for Food and Biotechnology AB.
Read more here (in English) www.mva.org/composite-1389.htm

UK-Medicon Valley Drug Development Seminar and Partnering Event
3 March 2005 / British Embassy / Copenhagen / Denmark
This seminar aims to explore each stage of the development of a drug, from pre-clinical through GMP manufacture to clinical trials. BioNow, Medicon Valley Academy and UK Trade & Industry at the British Embassy have arranged for a delegation of prestigious UK organisations to meet with their Danish counterparts. The seminar offers a two-way dialogue on leading-edge drug development. Targeted presentations followed by business partnering meetings with UK specialists and exclusive networking sessions will create privileged opportunities for future co-operation between Scandinavian and UK organisations.
Read more here (in English) www.mva.org/composite-1391.htm

MVA Annual Meeting 2005
30 March 2005 / Ørestad / Copenhagen / Denmark
Medicon Valley Academy invites to its Annual Meeting 2005. This year, focus will be on MVA's future strategic work within research and knowledge in Medicon Valley.
Read more here (in Danish) www.mva.org/composite-1318.htm

6th Medicon Valley - Hepatocyte User Group Meeting
6 April 2005 / Frederiksberg / Denmark
The Medicon Valley - Hepatocyte User Group Meeting (MV-HUG) invites to an afternoon meeting to discuss experiences on different medias/incubation conditions for hepatocyte applications - such as induction and metabolite ID studies - and to discuss best practice.
Read more here (in English) www.mva.org/composite-1373.htm

MVA Biostatistics Network Course: Clinical trial simulation in drug development
18-20 April 2005 / Lund / Sweden
The course is an introduction to the field of drug simulation. The course will cover topics like how modeling and simulation can contribute to drug development, simulation in drug development-good practice, simulation strategies, planning a CTS project, interpretation of simulation results, different softwares used in CTS and practical hands-on.
Read more here (in English) www.mva.org/composite-1135.htm


: MEDICON VALLEY NEWS

Symhogen  named among Europe's top 100 private tech companies by Tornador Insider
The Danish biotech company Symphogen A/S has been selected as one of the best-performing and innovative high-tech, private companies of Europe and Israel in the fourth annual Tornado 100 list. Symphogen, headquartered in Copenhagen, Denmark, specializes in pioneering recombinant natural human antibodies for the treatment and prevention of human disease.
Read more here (in English) www.mva.org/composite-1372.htm

MIP Technologies and FeF Chemicals, a subsidiary of Novo Nordisk, sign research and development agreement
Lund based MIP Technologies AB, a developer of molecular molecularly imprinted polymers for separations and drug discovery, recently announced that it has signed a research and development agreement with FeF Chemicals, a subsidiary of Novo Nordisk.
Read more here (in English) www.mva.org/composite-1369.htm

The Swedish Industrial Development Fund appoints new CEO
Claes de Neergaard was recently appointed new CEO for The Swedish Industrial Development Fund. Previously, he was Deputy CEO of the European Investment Bank, Executive Director of the European Bank for Reconstruction and Development and CEO of Nordbanken Luxemburg.
Read more here (in Swedish) www.mva.org/composite-1377.htm

Vivolution has been awarded with the prestigious Product Innovation Award for their Vivostat System
The Danish medical device company Vivolution A/S has been awarded the Frost & Sullivan Product Innovation Award 2004 for their Vivostat System - the only product in the world that produces surgical sealant based on the patient's own blood.
Read more here (in English) www.mva.org/composite-1358.htm

UK Global Partnership Programme
The UK Global Partnership initiative is sponsored by the UK Government to create partnerships between the world's most innovative technology-led organisations and their UK peers. E.g. it can help organisations in Medicon Valley of any size to find partners in the UK.
Read more here (in English) www.mva.org/composite-1382.htm

EU award to team led by Lund University Hospital and Lund University
The EMIT (European Medical Imaging Technology Transfer) education programme led by a team from Lund University Hospital and Lund University has won the prestigous Leonardo da Vinci EU Award.
Read more here (in Swedish) www.mva.org/composite-1361.htm

The Swedish Research Council's Industry PhD Programme
Apply for the Swedish Research Council's Industry PhD grants for collaborations between companies and universities within natural sciences and technology. Deadline: 19 April 2005.
Read more here (in Swedish) www.mva.org/composite-1368.htm

Ultrazonix raises SEK 30 million in a new investment round
The present owners, Scandinavian Life Science Ventures (SLSV) and Industrifonden are investing SEK 30 million in Malmö based Ultrazonix during 2005.
Read more here (in English) www.mva.org/composite-1367.htm


: FUTURE EVENTS - see all events

Commercialising bionanotechnology - the perspective from UK, Sweden & Denmark
9 February 2005 / Lund / Sweden
Speakers from Starbridge Systems, Farfield Sensors, and Qumat Technologies.
Read more here (in English) www.mva.org/composite-1366.htm

Life Sciences Conference: The Challenges within Pharmaceutical Production and Logistics
1 March 2005 / Copenhagen / Denmark
NNIT is pleased to welcome you to an interesting pharma conference day which will address some of the critical issues that many pharmaceutical companies are facing within production and logistics.
Read more here (in English) www.mva.org/composite-1363.htm

Course in Immunocytochemistry and immunohistochemistry
7 - 10 March 2005 / Copenhagen / Denmark
Kielberg Consult Aps offers an introduction to production of antibodies, together with an in-depth education in the immunocytochemical and immunohistochemical methods. The course includes 22 lectures presented by teachers with a strong research experience.
Read more here (in Danish) www.mva.org/composite-1379.htm

Antibody-based cancer drugs
15 March 2005 / Copenhagen / Denmark
This international one-day conference will examine the development of antibody therapeutic approaches to deliver individualised cancer drugs in the future.
Read more here (in English) www.mva.org/composite-1336.htm

Workshop on creation of biopharmaceutical development platform with involvement of biotech SME's
21-22 April 2005 / Barcelona / Spain
A consortium comprising a number of European organisations invites to a workshop on the structure, organisation, content and maintenance of a new European biopharmaceutical platform within the EU. The workhop presents discussion sessions on a number of important aspects on how a technological platform could be established, organised and maintained. A written report of the outcome will be issued and presented to the European Commission.
Read more here (in English) www.mva.org/composite-1375.htm

Tissue engineered blood vessels
23 - 24 April 2005 / Gothenburg / Sweden
Two-day international meeting with presentations on the subject of tissue engineered blood vessels, the extracellular matrix, and cell stress.
Read more here (in English) www.mva.org/composite-1321.htm

BioFinland 05 Investor Forum
26-27 April 2005 / Helsinki / Finland
BioFinland 05 Investor Forum will feature up to 25 selected high-potential biotech companies from the Scandinavian and Baltic countries.
Read more here (in English) www.mva.org/composite-1357.htm

ERBI's 7th Cambridge Biopartnering Exchange Event
4-5 May 2005 / Cambridge / UK
Meet Europe's most successful biotech entrepreneurs at ERBI's 7th Bio-partnering Exchange. The meeting is limited to 450 senior level delegates; a guarantee that you meet the people who will make an impact on your business. With over 30 presentations from innovative biotechnology companies in Cambridge.
Read more here (in English) www.mva.org/composite-1380.htm


: NEW MVA MEMBERS - see complete membership list

Copenhagen Business School /  www.cbs.dk
Copenhagen Business School (CBS) has around 14,000 students and an annual intake of around 1,000 exchange students. With this number of students as well as around 400 full-time researchers and around 500 administrative employees, CBS is the one of the three largest business school in Northern Europe. CBS aims to contribute to the creation of value in society and in enterprises; to train Master's graduates who are competitive in an international labour market; and to develop research-based knowledge in partnership with the business community.